Manus Aktteva
We are only a phone call away, Call us on: +91 79 65123395
+91 79 26463395
Home
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Manus Aktteva Biopharma LLP, projects, Products, Services, Quality Policy, Quality Management System, customer satisfaction,sourcing molecules, custom synthesis,FTE basis, DMF filing, penultimate stage, n-2, documentations, regulatory,FDA requirements,DMF
Products A to Z
       
General Info
Latest News
- EDQM set to implement European Pharmacopoeia Version 6.8 in June 2010
European Directorate for the Quality of Medicines & HealthCare (EDQM) will
Customer Feedback
Customer Commitment Statement

The
Management Message:

Dear Customer,

Thank you very much for choosing Manus Aktteva Biopharma LLP as your strategic partner and reposing faith on us and working with us on your ongoing and new projects.

I understand that every time you choose Manus Aktteva Biopharma LLP, you are placing your confidence and trust in us - in our 'Products', our 'Services' and our 'People'. Your expectations from us are undoubtedly high and that's what keeps us continuously trying to improve ourselves.

This “Quality Policy” statement from Manus Aktteva is a core step in our offered services being competitive, swift, efficient and exhaustive, continually improving the effectiveness of Quality Management Systems based on our core values of  'customer satisfaction', 'accountability' and 'teamwork.'

Our company policy addresses all areas of your sourcing requirement- starting from finding a source for hard to find molecules to organizing custom synthesis for a specific project and facilitating custom synthesis on FTE basis. Handling projects which are earmarked for your DMF filing by offering your required intermediates i.e. penultimate stage, n-2 stages backed up with documentations complying to regulatory requirements, complying with FDA requirements for the intermediates helping you file DMF, offering a technical package, to finally fulfilling commercial aspect of the project and beyond is what we specialize in.
The above reflects our vision, "THE MANUS AKTTEVA FAMILY WILL CONSISTENTLY DELIVER SWIFT, VALUE BASED AND SATISFACTORY SERVICE TO ALL OUR CUSTOMERS", and demonstrates our commitment to making your request an experience that could only be summed up by the words: "Test us to get the best of us".

It may not be out of place to share with you the fact that the last surveillance audit of ISO 9001:2008 certification highlighted 97% customer satisfaction reports.
It is our continuous endeavor to meet and exceed our customer’s expectations. I would like you to tell me how we are performing and I welcome your feedback.
Cheers!
 
Udeet J Banker
CEO
Manus Aktteva Biopharma LLP
 
Please click here to give us your feedback by filling up the Customer Feedback Form.
NOTE: 
  • Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS: 
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  CAS#
  Molecular Formula
Quick Help
Services
Our Participation
Queries
Tel1: +91 79 65123395
Tel2: +91 79 26463395
Email: click here
© 2017 MANUS AKTTEVA  All rights reserved..
Payment Procedure